WO2004098636A8 - Vaccinating against infectious diseases using proteosomes - Google Patents

Vaccinating against infectious diseases using proteosomes

Info

Publication number
WO2004098636A8
WO2004098636A8 PCT/US2004/014236 US2004014236W WO2004098636A8 WO 2004098636 A8 WO2004098636 A8 WO 2004098636A8 US 2004014236 W US2004014236 W US 2004014236W WO 2004098636 A8 WO2004098636 A8 WO 2004098636A8
Authority
WO
WIPO (PCT)
Prior art keywords
proteosomes
infectious diseases
against infectious
vaccinating against
vaccinating
Prior art date
Application number
PCT/US2004/014236
Other languages
French (fr)
Other versions
WO2004098636A2 (en
WO2004098636A3 (en
Inventor
David Hugh Jones
David S Burt
George H Lowell
Original Assignee
Id Biomedical Corp Quebec
David Hugh Jones
David S Burt
George H Lowell
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Id Biomedical Corp Quebec, David Hugh Jones, David S Burt, George H Lowell filed Critical Id Biomedical Corp Quebec
Priority to JP2006514314A priority Critical patent/JP2006525373A/en
Priority to EP04760725A priority patent/EP1622641A2/en
Priority to AU2004235815A priority patent/AU2004235815A1/en
Priority to CA002524485A priority patent/CA2524485A1/en
Publication of WO2004098636A2 publication Critical patent/WO2004098636A2/en
Publication of WO2004098636A3 publication Critical patent/WO2004098636A3/en
Publication of WO2004098636A8 publication Critical patent/WO2004098636A8/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/07—Bacillus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6087—Polysaccharides; Lipopolysaccharides [LPS]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Methods for making and using therapeutic formulations of Proteosome-based immunoactive compositions are provided.
PCT/US2004/014236 2003-05-05 2004-05-05 Vaccinating against infectious diseases using proteosomes WO2004098636A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2006514314A JP2006525373A (en) 2003-05-05 2004-05-05 Vaccination against infectious diseases using proteosomes
EP04760725A EP1622641A2 (en) 2003-05-05 2004-05-05 Vaccinating against infectious diseases using proteosomes
AU2004235815A AU2004235815A1 (en) 2003-05-05 2004-05-05 Vaccinating against infectious diseases using proteosomes
CA002524485A CA2524485A1 (en) 2003-05-05 2004-05-05 Vaccinating against infectious diseases using proteosomes

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46762403P 2003-05-05 2003-05-05
US60/467,624 2003-05-05

Publications (3)

Publication Number Publication Date
WO2004098636A2 WO2004098636A2 (en) 2004-11-18
WO2004098636A3 WO2004098636A3 (en) 2005-05-19
WO2004098636A8 true WO2004098636A8 (en) 2005-08-18

Family

ID=33435094

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/014236 WO2004098636A2 (en) 2003-05-05 2004-05-05 Vaccinating against infectious diseases using proteosomes

Country Status (5)

Country Link
EP (1) EP1622641A2 (en)
JP (1) JP2006525373A (en)
AU (1) AU2004235815A1 (en)
CA (1) CA2524485A1 (en)
WO (1) WO2004098636A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7255867B2 (en) 2002-11-15 2007-08-14 Id Biomedical Corporation Of Quebec Vaccine
JP4966661B2 (en) 2003-10-22 2012-07-04 アイディー バイオメディカル コーポレイション オブ ケベック Compositions and methods for activating innate and allergic immunity
EP2068834A2 (en) * 2006-09-08 2009-06-17 Becton, Dickinson & Company Stable powder formulations of aluma-dsorbed vaccines

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020051791A1 (en) * 1999-12-22 2002-05-02 Galloway Darrel R. Methods for protection against lethal infection with bacillus anthracis
EP1372706B1 (en) * 2001-03-09 2010-12-01 ID Biomedical Corporation of Quebec Proteosome-liposaccharide vaccine adjuvant

Also Published As

Publication number Publication date
AU2004235815A1 (en) 2004-11-18
CA2524485A1 (en) 2004-11-18
WO2004098636A2 (en) 2004-11-18
WO2004098636A3 (en) 2005-05-19
JP2006525373A (en) 2006-11-09
EP1622641A2 (en) 2006-02-08

Similar Documents

Publication Publication Date Title
WO2002080965A3 (en) Vaccine composition
WO2004080398A3 (en) 1-amino 1h-imidazoquinolines
WO2003072035A8 (en) Compositions and methods for the treatment of immune related diseases
WO2004041170A9 (en) Compositions and methods for the treatment of immune related diseases
WO2004094596A8 (en) Novel immunogenic compositions for the prevention and treatment of meningococcal disease
PL351893A1 (en) Vaccines
WO2003002136A3 (en) Stable formulation of modified glp-1
WO2004024097A9 (en) Compositions and methods for the treatment of immune related diseases
WO2003096990A3 (en) Protein cages for the delivery of medical imaging and therapy
ATE413188T1 (en) HUMAN PAPILLOMAVIRUS VACCINE FORMULATIONS
AU2002324914A1 (en) Pharmaceutical compositions of drug-oligomer conjugates and methods of treating diseases therewith
ZA200707934B (en) Thereapeutic formulations for the treatment of beta-amyloid related diseases
WO2004091572A3 (en) Cochleate compositions directed against expression of proteins
AU2001241918A1 (en) Methods of enhancing activity of vaccines and vaccine compositions
AU2002312303A1 (en) Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
AU2003236156A1 (en) Pharmaceutical compositions used for immune disease treatment and improvement
AU2003282498A1 (en) Hiv vaccine formulations
EP1583506A3 (en) Eye-drop vaccine containing copolymer 1 for therapeutic immunization
EP1534295A4 (en) Formulations and methods of administration of cephalotaxines, including homoharringtonine
AU2002359618A1 (en) Medicinal compositions and therapeutic methods
WO2001070265A3 (en) Lipopeptide adjuvants
WO2004030631A3 (en) Anti-cancer and anti-infectious disease compositions and methods for using same
WO2004024076A8 (en) Novel compositions and methods for the treatment of immune related diseases
WO2004098636A3 (en) Vaccinating against infectious diseases using proteosomes
EP1594531A4 (en) Storage-stable and bio-stable formulations of ace inhibitors, and methods for preparation thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
CFP Corrected version of a pamphlet front page

Free format text: UNDER (54) PUBLISHED TITLE REPLACED BY CORRECT TITLE

WWE Wipo information: entry into national phase

Ref document number: 2524485

Country of ref document: CA

Ref document number: 2006514314

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2004235815

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2004760725

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2004235815

Country of ref document: AU

Date of ref document: 20040505

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2004235815

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2004760725

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2004760725

Country of ref document: EP